Search

everythinglearnresearchcommunity

for

Search:↓

Ruxolitinib helped a patient with alopecia areata regrow hair.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Lack of KSR1 stops certain skin tumors in mice.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

Injury boosts normal skin cell growth, reducing cancer cell advantage.

Presurgical models can effectively and affordably screen cancer prevention agents.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Cetuximab can cause unusual hair growth and hair loss.

Checkpoint inhibitor therapy can cause skin issues, from mild rashes to severe reactions.

L-cystine and vitamin B6 at high doses prevented hair loss in mice treated with a chemotherapy drug.

Blocking DPP4 can potentially speed up hair growth and regeneration, especially after injury or in cases of hair loss.

Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Cetuximab often causes skin problems, but they can be managed without stopping treatment.

FOLFOX6 chemotherapy effectively reduces VEGF levels and improves quality of life in advanced colorectal cancer patients.

JAK inhibitors show promise for treating various skin diseases.

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Tofacitinib, a JAK inhibitor, improved hair regrowth in most patients with severe alopecia areata and had minimal side effects.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.